Vimta Labs Limited (VIMTALABS) Financial History

Name: Vimta Labs Limited (VIMTALABS) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-09-20

Vimta Labs Limited (VIMTALABS) operates in the Diagnostics & Research industry and is headquartered in Hyderabad, India with about 1,384 employees. Its market capitalization is roughly ₹27 billion. In the fiscal year ended 2026-03-31, VIMTALABS reported ₹4.1B in revenue and ₹775M in net income.

Vimta Labs Limited provides contract research and testing services in India and internationally.

Interactive charts & full statements →

VIMTALABS Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹4.1B	₹3.4B	₹2.9B	₹3.2B
Gross Profit	₹3.3B	₹2.7B	₹2.3B	₹2.4B
Operating Income (EBIT)	₹1.1B	₹906M	₹645M	₹697M
Net Income	₹775M	₹673M	₹410M	₹482M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VIMTALABS Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	₹1.1B	₹1.1B	₹986M	₹1.0B	₹976M	—
Gross Profit	₹864M	₹868M	₹793M	₹817M	₹788M	—
Operating Income (EBIT)	₹248M	₹266M	₹233M	₹240M	₹238M	—
Net Income	₹210M	₹211M	₹176M	₹199M	₹189M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VIMTALABS Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹44M)	(₹44M)	(₹44M)	(₹44M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

VIMTALABS Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹5.6B	₹4.7B	₹3.9B	₹3.6B	—
Total Liabilities	₹1.1B	₹877M	₹804M	₹805M	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VIMTALABS viewer.

Other Companies in Diagnostics & Research

2395 · Shin Nippon Biomedical Laboratories, Ltd. — JPY 55 billion
3347 · Hangzhou Tigermed Consulting Co., Ltd — HK$39 billion
LONN · Lonza Group AG — CHF 38 billion
4671 · FALCO HOLDINGS Co., Ltd. — JPY 29 billion
6127 · Joinn Laboratories(China)Co.,Ltd. — HK$19 billion
KRSNAA · Krsnaa Diagnostics Limited — ₹18 billion
SURAKSHA · Suraksha Diagnostic Limited — ₹17 billion
ERF · Eurofins Scientific SE — €13 billion

← VILR All “V” companies VINATIORGA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.